EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma

Claire Godier, Zakaria Baka, Laureline Lamy, Varvara Gribova iD, Philippe Marchal, Philippe Lavalle, Eric Gaffet iD, Lina Bezdetnaya, Halima Alem iD

Diseases · 10.09.2024 · 12 (9) · 206

DOI: 10.3390/diseases12090206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases, online erschienen am 10.09.2024. Verfasst von Claire Godier und 8 weiteren Autor:innen. Beteiligte Einrichtung: IJL, CNRS, Université de Lorraine, 54000 Nancy, France. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut Universitaire de France, French PIA project "Lorraine Université d'Excellence", Ministry of Higher Education, Innovation, and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a disease with a very poor prognosis, characterized by incidence rates very close to death rates. Despite the efforts of the scientific community, preclinical models that faithfully recreate the PDAC tumor microenvironment remain limited. Currently, the use of 3D bio-printing is an emerging and promising method for the development of cancer tumor models with reproducible heterogeneity and a precisely controlled structure. This study presents the development of a model using the extrusion 3D bio-printing technique. Initially, a model combining pancreatic cancer cells (Panc-1) and cancer-associated fibroblasts (CAFs) encapsulated in a sodium alginate and gelatin-based hydrogel to mimic the metastatic stage of PDAC was developed and comprehensively characterized. Subsequently, efforts were made to vascularize this model. This study demonstrates that the resulting tumors can maintain viability and proliferate, with cells self-organizing into aggregates with a heterogeneous composition. The utilization of 3D bio-printing in creating this tumor model opens avenues for reproducing tumor complexity in the future, offering a versatile platform for improving anti-cancer therapy models.

Schlagwörter

Stichwörter der Autor:innen

3D bio-printingco-culturepancreatic ductal adenocarcinoma

Autor:innen und Institutionen

  • IJL, CNRS, Université de Lorraine, 54000 Nancy, France.
  • CRAN, CNRS, Université de Lorraine, 54506 Vandœuvre-lès-Nancy, France.
  • Département Recherche, Institut de Cancérologie de Lorraine (ICL), 6 Avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France.
  • Institut National de la Santé et de la Recherche Médicale (INSERM) U1121, Biomaterials and Bioengineering, 1 rue Eugène Boeckel, 67100 Strasbourg, France.
  • Faculté de Chirurgie Dentaire, Université de Strasbourg, 8 rue Sainte Elisabeth, 67000 Strasbourg, France.
  • LRGP, CNRS, Université de Lorraine, 54000 Nancy, France.

ORCID-Profile: Varvara Gribova, Eric Gaffet, Halima Alem

Förderung

  • Institut Universitaire de France
  • French PIA project "Lorraine Université d'Excellence"
  • Ministry of Higher Education, Innovation, and Research
  • French PIA project “Lorraine Université d’Excellence”

Zitieren

APA

Godier, C., Baka, Z., Lamy, L., Gribova, V., Marchal, P., Lavalle, P., Gaffet, E., Bezdetnaya, L., & Alem, H. (2024). A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma. Diseases, 12(9), 206. https://doi.org/10.3390/diseases12090206

Vancouver

Godier C, Baka Z, Lamy L, Gribova V, Marchal P, Lavalle P, et al. A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma. Diseases. 2024;12(9):206. doi:10.3390/diseases12090206

BibTeX
@article{Godier2024,
  author = {Godier, Claire and Baka, Zakaria and Lamy, Laureline and Gribova, Varvara and Marchal, Philippe and Lavalle, Philippe and Gaffet, Eric and Bezdetnaya, Lina and Alem, Halima},
  title = {A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma},
  journal = {Diseases},
  year = {2024},
  volume = {12},
  number = {9},
  pages = {206},
  doi = {10.3390/diseases12090206}
}
Kostenlos starten →